DOD Peer Reviewed Cancer, Career Development Award – Scholar Option
ID: 359095Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359095
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Peer Reviewed Cancer Research Program (PRCRP) Career Development Award – Scholar Option (CDA-SO) for fiscal year 2025. This grant aims to support independent early-career investigators, referred to as Scholars, in conducting impactful cancer research under the mentorship of an experienced Career Guide, with a focus on military health-related cancer issues. The program has an estimated total funding of approximately $9.9 million, with about nine awards anticipated, each capped at $1.1 million. Interested applicants must submit a pre-application by June 19, 2025, followed by a full application due by July 3, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942525PRCRPCDASO_GG.pdf
    The Department of Defense (DoD) announces the Peer Reviewed Cancer Research Program (PRCRP) Career Development Award – Scholar Option (CDA-SO) for fiscal year 2025, aimed at supporting independent, early-career investigators in significant cancer research. The program allocates approximately $9.9 million, funding about nine award applications with a cap of $1.1 million for each. Eligible applicants include both extramural and intramural organizations, focusing on specific cancer types that are relevant to military health. The application process comprises a pre-application due by June 19, 2025, followed by a full application by July 3, 2025. Key elements of the application include designation of a Career Guide for mentorship, a career development plan, and the need to demonstrate relevance to military health issues. The proposed research must address one of the designated FY25 PRCRP topic areas, which exclude melanoma and certain breast, prostate, and ovarian cancers. Unique to this award is the requirement for scholarship participation in a Virtual Cancer Center aimed at collaboration and enhanced research outcomes for cancer treatment and patient care. This funding opportunity underscores the DoD’s commitment to advancing cancer research while addressing critical needs within the military community.
    Similar Opportunities
    NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08), aimed at fostering diversity within the cancer research workforce. This grant supports clinical scientists with doctoral degrees who are underrepresented in health-related research, providing salary support for a 3-5 year period to gain intensive research training in various cancer research fields, particularly focusing on health disparities. The program is designed to enhance the research capabilities of awardees, preparing them for independent research careers in basic biomedical, behavioral, or translational cancer research. Interested applicants should note that the application period opens on January 12, 2025, with a submission deadline of February 12, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-320.html.
    Staff Research Program
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a funding opportunity for the Staff Research Program, aimed at engaging scientific staff in collaborative research with higher education institutions. This program seeks to enhance the professional competence of Army Research Office (ARO) scientists through hands-on, fundamental research in various scientific fields, including engineering, physical sciences, and life sciences, with a focus on advancing knowledge relevant to Army missions. Eligible applicants include institutions recognized for their scientific research capabilities, and the funding will be provided through cooperative agreements with award amounts ranging from $200,000 to $10 million. Proposals must be submitted via Grants.gov by June 2, 2030, and interested parties can contact Mr. William Creech at William.a.creech3.civ@army.mil for further information.
    Notice of Intent to Publish Funding Opportunity Announcement for NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is planning to publish a Notice of Funding Opportunity for the NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32), which will support early postdoctoral fellows in cancer research. This grant program aims to enhance the pool of qualified individuals from diverse backgrounds for careers in health-related research, particularly in cancer, by providing research training opportunities that do not require preliminary data. The program is significant for addressing cancer health disparities and enriching the scientific research experience for trainees transitioning from pre-doctoral to post-doctoral training. Interested applicants must identify a postdoctoral research mentor and submit their applications through their respective institutions, with the application deadline set for June 12, 2025, and an estimated award date of March 2, 2026.
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Development Command (USAMRDC), has announced the FY23-FY27 Broad Agency Announcement (BAA) for Extramural Medical Research, which is open for submissions from October 1, 2022, to September 30, 2027. This opportunity invites innovative research proposals that address critical military medical challenges, particularly in the areas of Military Infectious Diseases, Combat Casualty Care, and Military Operational Medicine, with a focus on enhancing medical practices for both military personnel and civilians. The BAA emphasizes the importance of collaboration with Department of Defense and Department of Veterans Affairs resources and requires adherence to strict submission guidelines via Grants.gov and the electronic Biomedical Research Application Portal (eBRAP). Interested applicants can submit pre-proposals at any time during the five-year period, with full proposals invited based on initial submissions, and should direct inquiries to the CDMRP Help Desk at help@eBRAP.org.
    Forecast to Publish a Notice of Funding Opportunity for Paul Calabresi Career Development Award in Clinical Oncology (K12 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the Paul Calabresi Career Development Award in Clinical Oncology (K12), aimed at enhancing the training of clinical scientists in cancer research. This grant program is designed to support institutional research career development programs that will increase the number of clinician-scientists engaged in clinical and translational cancer research, fostering their career development through tailored mentorship and individualized plans. The program will fund a total of 15 awards, with support for a minimum of two years and a maximum of three years for each scholar, covering salary, research, and administrative costs. Interested applicants can reach out to Mark Damico, Ph.D., at damicomw@nih.gov or call 240-276-5630 for further information, with the estimated synopsis posting date on December 1, 2025, and applications expected to close by February 18, 2026.
    NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08), aimed at training individuals with clinical doctoral degrees for impactful careers in health-related research, particularly in cancer studies. This program is designed to support individuals from underrepresented backgrounds in health-related sciences, providing them with a mentored research career development experience over a period of 3 to 5 years, focusing on biomedical, behavioral, and clinical research, including clinical trials. Successful applicants are expected to commit at least 75% of their time to the project and will receive funding for salary and research-related expenses, with applications due at specific intervals starting January 12, 2025. For further information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-319.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for Academic Career Excellence (ACE) Award (K32 � Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing the upcoming Academic Career Excellence (ACE) Award (K32), aimed at supporting late-stage graduate students and early-stage postdoctoral scholars in cancer research. This grant opportunity is designed to enhance the scientific research and career development experience of candidates transitioning to postdoctoral positions, requiring applicants to have a well-defined research and training plan with an identified mentor. The ACE Award is critical for fostering the next generation of cancer researchers, with applications expected to open on June 12, 2025, and an estimated award date of March 2, 2026. Interested applicants should prepare their proposals in advance, as there are no cost-sharing requirements, and the funding will be available under CFDA number 93.398.
    Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Specialized Programs of Research Excellence (SPOREs) in Human Cancers, specifically for the fiscal years 2027, 2028, and 2029, under the P50 Clinical Trial Required grant program. This initiative aims to fund innovative translational research that enhances prevention, early detection, diagnosis, and treatment of organ-specific cancers or closely related cancer groups, utilizing advanced cellular, molecular, and genetic approaches. With an estimated total program funding of $25 million and the expectation of awarding 12 grants, interested applicants must submit their proposals by January 25, 2027, with the anticipated award date set for June 4, 2027. For further inquiries, applicants can contact Bradley T. Scroggins at bradley.scroggins@nih.gov or by phone at 240-276-7860.
    Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for Specialized Programs of Research Excellence (SPOREs) in Human Cancers, aimed at supporting innovative translational research from 2024 to 2026. This initiative invites applications for P50 Research Center Grants that focus on enhancing cancer prevention, early detection, diagnosis, and treatment, particularly for organ-specific cancers or related groups, with a requirement for at least one clinical trial component in each application. The program is crucial for advancing cancer research and addressing health disparities, with funding available up to $1,400,000 in direct costs per year over a five-year project period. Interested applicants can find more information and application guidelines at the NIH website and should direct inquiries to grantsinfo@nih.gov, with the application deadline set for September 25, 2026.
    Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)," aimed at enhancing the training of a workforce to meet the nation’s biomedical and clinical research needs, particularly in cancer research. This program seeks applications that propose innovative educational activities, specifically hands-on cancer research experiences lasting 8 to 15 weeks, complemented by additional educational initiatives. With a funding ceiling of $300,000 per year for a project period of up to five years, the program encourages participation from underrepresented groups and aims to provide unique educational opportunities not covered by existing programs. Interested applicants can find more information and guidelines at the NIH website, with the application deadline set for January 25, 2026.